Amgen, AstraZeneca prep a brodalumab pitch–after scuttling asthma program – FierceBiotech

Amgen, AstraZeneca prep a brodalumab pitch–after scuttling asthma program
FierceBiotech
Amgen and its partner AstraZeneca are winding up to deliver U.S. and European applications for their big blockbuster hopeful brodalumab for plaque psoriasis by mid-year. But their last shot to push ahead with the drug in asthma ran into defeat, with

View full post on asthma – Google News